BHAGAVAN JALADI

Performed posterolateral L4–L6 spinal fusion in 120 rats with <10% surgical attrition and improved micro-CT reproducibility by 3.2×. Built osteomyelitis models using bioluminescent S. aureus imaging and isolated adipose-derived MSCs with ≥85% viability within two weeks.

Compiled a 1,200-species physiology dataset, accelerating cross-species analyses by 60%. Curated zoo and literature data from 200+ publications and reduced retrieval and data-cleaning effort by 30–40% using standardized templates and QA checks.

Ran MSC–fibroblast/epithelial co-culture migration assays, achieving 1.5–2× increased migration with secretome treatment. Optimized conditioned-media paracrine signaling and wound-healing readouts, increasing assay throughput by 3× via automated image analysis.

Maintained MSC, hiPSC, and multiple cell lines with <5% contamination across 200+ culture batches and trained students over three semesters. Implemented controlled-rate cryopreservation protocols with 70–90% post-thaw recovery consistency and improved batch reproducibility by 25% using imaging-based morphology/viability monitoring.

Performed ctDNA isolation and PCR workflows, reliably detecting 0.1% mutant allele fractions. Conducted Western blots and organoid drug-response evaluation, and implemented SOP/LIMS documentation that improved data retrieval speed by 20%.

Formulated ciprofloxacin emulgels using natural oils with sustained-release performance, supporting publication outcomes. Developed floating carvedilol tablets with validated 12-hour sustained release and synthesized silver nanoparticles showing ≥30% inhibition against E. coli and S. aureus.

Pursuing a Master of Science in Biotechnology at Johns Hopkins University, expected to complete in May 2026.

Completed a Bachelor of Pharmacy at Krishna University, completed in June 2023.